The Leukemia & Lymphoma Society (LLS) is a nonprofit organization that serves both patients and healthcare providers. LLS helps fund clinical research for lymphoma and other blood cancers. They also provide educational resources for both healthcare providers and patients and their caregivers and are active in advocacy by driving policies and legislation that accelerate the development of new cancer treatments.
The International Prognostic Index Calculator provides the prognostic scores for individual patients based on risk factors such as age, ECOG performance status, and others.
This interactive PDF offers a patient-centric breakdown of the NCCN Guidelines for B-Cell Lymphomas, including DLBCL. The guidelines review the disease overview of DLBCL, steps to diagnosis and workup, and treatment guides for both the upfront and relapsed/refractory settings.
Clinical trials are always a great option for DLBCL patients, and there are many studies currently enrolling patients. Take a look at clinicaltrials.gov to see if your patient qualifies for any ongoing trials and discuss them as a potential treatment option.
The Lymphoma Research Foundation focuses on lymphoma research, advocacy, and education by bringing together researchers, clinicians, and patients. The website provides education on lymphoma throughout the disease trajectory, links to educational resources, support for patients and caregivers, and ongoing information about new discoveries in lymphoma.
